These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1097 related items for PubMed ID: 25986173

  • 1. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R, Kommoss S, Winterhoff BJ, Kipp BR, Garcia JJ, Voss J, Halling K, Karnezis A, Senz J, Yang W, Prigge ES, Reuschenbach M, Doeberitz MV, Gilks BC, Huntsman DG, Bakkum-Gamez J, McAlpine JN, Anglesio MS.
    BMC Cancer; 2015 May 19; 15():415. PubMed ID: 25986173
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular diagnosis in type I epithelial ovarian cancer.
    Sadłecki P, Walentowicz-Sadłecka M, Grabiec M.
    Ginekol Pol; 2017 May 19; 88(12):692-697. PubMed ID: 29303228
    [Abstract] [Full Text] [Related]

  • 5. Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver.
    Emmanuel C, Chiew YE, George J, Etemadmoghadam D, Anglesio MS, Sharma R, Russell P, Kennedy C, Fereday S, Hung J, Galletta L, Hogg R, Wain GV, Brand A, Balleine R, MacConaill L, Palescandolo E, Hunter SM, Campbell I, Dobrovic A, Wong SQ, Do H, Clarke CL, Harnett PR, Bowtell DD, deFazio A, Australian Ovarian Cancer Study (AOCS).
    Clin Cancer Res; 2014 Dec 15; 20(24):6618-30. PubMed ID: 25316818
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer.
    Nodin B, Zendehrokh N, Sundström M, Jirström K.
    Diagn Pathol; 2013 Jun 25; 8():106. PubMed ID: 23800114
    [Abstract] [Full Text] [Related]

  • 7. Histotype-specific copy-number alterations in ovarian cancer.
    Huang RY, Chen GB, Matsumura N, Lai HC, Mori S, Li J, Wong MK, Konishi I, Thiery JP, Goh L.
    BMC Med Genomics; 2012 Oct 18; 5():47. PubMed ID: 23078675
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and RAS pathway aberrations.
    Hunter SM, Gorringe KL, Christie M, Rowley SM, Bowtell DD, Australian Ovarian Cancer Study Group, Campbell IG.
    Clin Cancer Res; 2012 Oct 01; 18(19):5267-77. PubMed ID: 22891197
    [Abstract] [Full Text] [Related]

  • 11. Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials.
    Meagher NS, Schuster K, Voss A, Budden T, Pang CNI, deFazio A, Ramus SJ, Friedlander ML.
    Gynecol Oncol; 2018 Sep 01; 150(3):527-533. PubMed ID: 30054102
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improved classification of epithelial ovarian cancer: results of 3 danish cohorts.
    Steffensen KD, Waldstrøm M, Grove A, Lund B, Pallisgård N, Jakobsen A.
    Int J Gynecol Cancer; 2011 Dec 01; 21(9):1592-600. PubMed ID: 21926912
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
    Kim H, Kim BH, Lee D, Shin E.
    Pathol Res Pract; 2019 Oct 01; 215(10):152566. PubMed ID: 31400926
    [Abstract] [Full Text] [Related]

  • 16. An in vivo model for the study of ovarian cancer and the persistence of characteristic mutations in xenografts.
    Li Y, Gu YJ, Liu CN, Yue TF.
    Eur J Gynaecol Oncol; 2014 Oct 01; 35(4):387-92. PubMed ID: 25118479
    [Abstract] [Full Text] [Related]

  • 17. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.
    Enomoto T, Weghorst CM, Inoue M, Tanizawa O, Rice JM.
    Am J Pathol; 1991 Oct 01; 139(4):777-85. PubMed ID: 1656759
    [Abstract] [Full Text] [Related]

  • 18. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
    Shim HS, Kenudson M, Zheng Z, Liebers M, Cha YJ, Hoang Ho Q, Onozato M, Phi Le L, Heist RS, Iafrate AJ.
    J Thorac Oncol; 2015 Aug 01; 10(8):1156-62. PubMed ID: 26200269
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.